Whey Protein for Metabolic Bone Health
(BonePRO Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to investigate the effects of protein ingestion post-exercise on bone turnover markers. The main questions it aims to answer is: Does protein ingestion independently influence the bone metabolic response to exercise in endurance runners? We will compare dietary protein to a placebo (water) to detect changes in bone turnover markers. Participants will: In a within-subject design, participants will perform an exhaustive run and take either protein or placebo immediately post-exercise. Track physical activity and diet before each arm of the intervention and during the washout period.
Research Team
Jenna Gibbs, PhD
Principal Investigator
McGill University
Eligibility Criteria
This trial is for endurance runners who are interested in how protein affects their bone health after exercise. Participants should be healthy, with no metabolic bone diseases or conditions affecting metabolism. They must track their diet and activity, and not take other supplements that could influence the results.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Whey Protein Supplement
Find a Clinic Near You
Who Is Running the Clinical Trial?
McGill University
Lead Sponsor